Comparative Effectiveness of Ipsilesional High-frequency rTMS, Contralesional Continuous Burst Theta rTMS, and Sham rTMS, Each Combined With Physiotherapy, in Subacute Ischemic Stroke Upper Limb Recovery : Clinical, Neurophysiological and Radiological
NCT ID: NCT06799312
Last Updated: 2025-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
90 participants
INTERVENTIONAL
2025-03-15
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
rTMS Plus CCFES-mediated Functional Task Practice for Severe Stroke
NCT03870672
Primed vs. Unprimed rTMS in Chronic Stroke
NCT01757821
Effects of Repetitive Transcranial Magnetic Stimulation Therapy on Lower Extremity Motor Development in Stroke Patients
NCT05554861
Augmented Efficacy of rPMS on the rTMS on Upper Limb Function in Patients With Stroke
NCT05053711
Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Upper Extremity Motor Function in Stroke Patients
NCT05646134
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ipsilesional high frequency rTMS combined with physiotherapy
rTMS Protocol:
Stimulation delivered to the hand area of the ipsilesional primary motor cortex (M1).
Frequency: 3 Hz.
Stimulation: 2 seconds per train, 37 trains per session.
Total pulses: 750 per session at 130% of the resting motor threshold (RMT).
Physiotherapy:
Patients receive standard physiotherapy sessions.
Ipsilesional high frequency rTMS combined with physiotherapy
As mentioned in details in arms description.
Contralesional Continuous Burst Theta rTMS (cTBS) + Physiotherapy
rTMS Protocol:
Stimulation delivered to the contralesional primary motor cortex (M1).
Protocol: Continuous bursts of 3 stimuli at 50 Hz, repeated at 5 bursts per second.
Duration: 40 seconds per session.
Stimulation intensity: 70% of RMT with a biphasic TMS-induced current at a 45° angle to the midline.
Physiotherapy:
Patients receive standard physiotherapy sessions.
Contralesional Continuous Burst Theta rTMS (cTBS) + Physiotherapy
As mentioned in details in arms description.
Sham rTMS + Physiotherapy
Patients receive a sham stimulation designed to mimic rTMS without delivering active magnetic pulses.
This maintains blinding for participants and investigators.
Physiotherapy:
Patients receive standard physiotherapy sessions.
Sham rTMS + Physiotherapy
As mentioned in details in arms description.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ipsilesional high frequency rTMS combined with physiotherapy
As mentioned in details in arms description.
Contralesional Continuous Burst Theta rTMS (cTBS) + Physiotherapy
As mentioned in details in arms description.
Sham rTMS + Physiotherapy
As mentioned in details in arms description.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stroke affecting the non-dominant hemisphere (cortical or subcortical) within the middle cerebral artery (MCA) territory.
* Acute to subacute stage of stroke (time since onset: 48 hours to 2 weeks).
* Ability to comply with the study protocol and interventions.
Exclusion Criteria
* Severe cognitive impairment, defined as a Montreal Cognitive Assessment (MoCA) score \< 10.
* Contraindications to TMS, such as: History of epilepsy, Metallic implants in the head, Other contraindications based on TMS safety guidelines.
* Comorbid conditions that limit participation in rehabilitation.
* Severe neglect or aphasia that would impede participation in therapy.
40 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohammad Ahmad Mohammad Korayem
Assisstant lecturer
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Related Info
Related Info
Related Info
Related Info
Related Info
Related Info
Related Info
Related Info
Related Info
Related Info
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NeuroRehabStroke2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.